Travel

"While developing a rapid test that detects the coronavirus in someone’s saliva, Blink Science, a Florida-based startup, heard something startling: The Food and Drug Administration had more than 3,000 emergency use authorization applications and didn’t have the resources to get through them." "The U.S. produced covid-19 vaccines in record time, but, nearly two years into the pandemic, consumers have few options for cheap tests that quickly screen for infection, though they are widely available in Europe. Experts say the paucity of tests and their high prices undermine efforts in the U.S. to return to normal life. more »

"This analysis of new daily cases of COVID-19, acute incidence of OD [Olfactory Dysfunction], and rates of recovery suggest that more than 700,000, and possibly as many as 1.6 million, US individuals experience COD because of SARS-CoV-2. To put this number in context, before the COVID-19 pandemic, the National Institute on Deafness and Other Communication Disorders estimated that, among US adults 40 years or older, measurable OD was found in up to 13.3 million adults.6 Notably, the age-specific prevalence of OD is 4.2% for individuals between age 40 to 49 years and 39.4% for individuals 80 years and older." "The loss of olfaction has been associated with decreased general quality of life, impaired food intake, inability to detect harmful gas and smoke, enhanced worries about personal hygiene, diminished social well-being, initiation of depressive symptoms." more »

Policymakers could provide support for public-private partnerships to strategically address potential pandemic pathogens identified as priorities. These partnerships could, for example, develop and test vaccine candidates that may provide protection from pathogens with pandemic potential. This early development could provide a coordinated foundation that can be mobilized in an emergency. Such an approach could speed vaccine development as well as potentially reduce risk for vaccine researchers and developers concerning questions of safety, efficacy, and manufacturability. The lack of certainty of the commercial market and government funding for vaccines against pathogens with pandemic potential may be too risky for the private sector to undertake. more »

"Despite acting swiftly to assist Americans abroad, State did not follow some of its policies and lacked guidance for certain aspects of its repatriation effort. For example, as of May 2021, an interagency group State established to coordinate plans to evacuate U.S. citizens abroad in emergencies had not met since April 2019, hampering interagency communication early in the crisis. Also, incomplete guidance for calculating and documenting actual costs of State-chartered flights led to missing or inconsistent documentation and limited State's ability to show that the prices it charged passengers complied with its fare policy." more »